Novo Nordisk not currently in a position to pursue large-scale M&A, CEO says

Novo Nordisk not currently in a position to pursue large-scale M&A, CEO says is a pharma and life sciences industry update from Pharmaceutical Technology. The story may affect commercial strategy, market access planning, stakeholder engagement, competitive positioning, and near-term monitoring for pharmaceutical and biotech teams.

Robert Barrie · 2026-08-05

Set against the backdrop of a mixed Q2, Novo Nordisk is eyeing bolt-ons in favour of transformative acquisitions.

Source: Pharmaceutical Technology